[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335199-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335199-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mitochondrial-rewiring-with-small-molecule-drug-free-nanoassemblies-unleashes-anticancer-immunity","Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity","","Immunosuppressive tumor microenvironments limit immune checkpoint blockade efficacy by promoting immune evasion and reducing tumor-infiltrating T cells. The study reports small molecules that undergo aqueous self-assembly and selectively target cellular organelles, especially mitochondria, to increase tumor cell immunogenicity. The nanoassembly platform dynamically rewires mitochondria, induces endoplasmic reticulum stress, and drives apoptosis/paraptosis-associated immunogenic cell death. Stressed dying tumor cells then act as prophylactic or therapeutic cancer vaccines. In mouse cancer models with PD-1 resistance, local nanoassembly administration inflames immune-silent tumors and synergizes with ICB therapy to generate potent antitumor immunity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mitochondrial-rewiring-with-small-molecule-drug-free-nanoassemblies-unleashes-anticancer-immunity/335199/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mitochondrial-rewiring-with-small-molecule-drug-free-nanoassemblies-unleashes-anticancer-immunity/335199.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is immune checkpoint blockade often ineffective against tumors?","Question",{"text":63,"@type":64},"The immunosuppressive tumor microenvironment enables immune evasion and limits effective T-cell responses, so only a small subset of patients respond and many progress after initial partial response.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What do the drug-free small-molecule nanoassemblies do differently?",{"text":68,"@type":64},"They self-assemble in aqueous conditions and are designed to target cellular organelles such as mitochondria, reprogramming stressed tumor cells to become immunogenic rather than acting as conventional cytotoxic therapies.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the nanoassembly platform induce antitumor immunity?",{"text":72,"@type":64},"It dynamically rewires mitochondria, triggers endoplasmic reticulum stress, and causes apoptosis/paraptosis-associated immunogenic cell death, enabling stressed dying tumor cells to function as prophylactic or therapeutic cancer vaccines and to synergize with immune checkpoint blockade.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335199,1790169108,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article [https://doi.org/10.1038/s41467-024-51945-y](https://doi.org/10.1038/s41467-024-51945-y)  \nMitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity  \nReceived: 12 March 2024  \n\n| Accepted: 22 August 2024 |\n| --- |\n| |\n| Check for updates |\n\nLulu Ren1,2, Jianqin Wan1, Xiaoyan Li1,3, Jie Yao1,3, Yan Ma1, Fanchao Meng1, Shusen Zheng 1 , Weidong Han4  & Hangxiang Wang 1,2,5   \nThe immunosuppressive tumor microenvironment (TME) remains a major obstacle to tumor control and causes suboptimal responses to immune checkpoint blockade (ICB) therapy. Thus, developing feasible therapeutic strategies that trigger inﬂammatory responses in the TME could improve the ICB efﬁcacy. Mitochondria play an essential role in inﬂammation regulation and tumor immunogenicity induction. Herein, we report the discovery and characterization of a class of small molecules that can recapitulate aqueous self-assembly behavior, speciﬁcally target cellular organelles (e.g., mitochondria), and invigorate tumor cell immunogenicity. Mechanistically, this nanoassembly platform dynamically rewires mitochondria, induces endoplasmic reticulum stress, and causes apoptosis/paraptosis-associated immunogenic cell death. After treatment, stressed and dying tumor cells can act as prophylactic or therapeutic cancer vaccines. In preclinical mouse models of cancers with intrinsic or acquired resistance to PD-1 blockade, the local administration of nanoassemblies inﬂames the immunologically silent TMEand synergizes with ICB therapy, generating potent antitumor immunity. This chemically programmed small-molecule immune enhancer acts distinctly from regular cytotoxic therapeutics and offers a promising strategy for synchronous and dynamic tailoring ofinnate immunity to achieve traceless cancer therapy and overcome immunosuppression in cancers.  \nImmunotherapy has revolutionized clinical cancer treatment. In particular, immune checkpoint blockade (ICB) antibodies targeting the immunoregulatory receptors programmed death 1 (PD-1), programmed death-ligand1(PD-L1), and cytotoxic T lymphocyte antigen4 (CTLA-4) have had marked success against various human cancers1. However, only a small subset of patients responds to this therapy, and most of the partial responders eventually experience disease  \nprogression due to tumor immune evasion2. The majority ofbarriers to effective T-cell based immunotherapy results from a myriad offactors, including insufﬁcient tumor-inﬁltrating T lymphocytes (TILs), high immune suppressor contents, and low mutational burden3,4. Thus, abetter understanding of the immune landscape of the tumor microenvironment (TME) offers new therapeutic strategies to reverse protumor suppressive status and eventually unleash effector T cells.  \n1The First Afﬁliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, PR China. 2Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong Province, PR China. 3Department of Chemical Engineering, Zhejiang University, Hangzhou, Zhejiang Province, PR China. 4Department of Colorectal Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, PR China. 5Department of Hepatobiliary Surgery, The First Afﬁliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province, PR China.  \ne-mail: [shusenzheng@zju.edu.cn](shusenzheng@zju.edu.cn); [hanwd@zjcc.org.cn](hanwd@zjcc.org.cn); [wanghx@zju.edu.cn](wanghx@zju.edu.cn)  \nEmerging strategies to address this substantial clinical challenge have focused on improving ICB therapy with additional immunostimulatory agents or by developing new combination treatments5–8.  \nStressed and dying cancer cells emit numerous immunostimulatory molecules, including small metabolites, antig","cbCaiepcHS2lZyS7","https://ap.wps.com/l/cbCaiepcHS2lZyS7","pdf",9769833,"English","# Introduction\n## Immune checkpoint blockade and tumor microenvironment barriers\n## Immunogenic cell death and mitochondria as targets\n# Results and Methods\n## Development of small-molecule nanoassemblies targeting mitochondria\n## Nanostructure formation and enhanced tumor immunogenicity\n# Mechanism\n## Organelle rewiring, endoplasmic reticulum stress, and cell death\n## Vaccine-like effects and synergy with ICB","[{\"question\":\"Why is immune checkpoint blockade often ineffective against tumors?\",\"answer\":\"The immunosuppressive tumor microenvironment enables immune evasion and limits effective T-cell responses, so only a small subset of patients respond and many progress after initial partial response.\"},{\"question\":\"What do the drug-free small-molecule nanoassemblies do differently?\",\"answer\":\"They self-assemble in aqueous conditions and are designed to target cellular organelles such as mitochondria, reprogramming stressed tumor cells to become immunogenic rather than acting as conventional cytotoxic therapies.\"},{\"question\":\"How does the nanoassembly platform induce antitumor immunity?\",\"answer\":\"It dynamically rewires mitochondria, triggers endoplasmic reticulum stress, and causes apoptosis/paraptosis-associated immunogenic cell death, enabling stressed dying tumor cells to function as prophylactic or therapeutic cancer vaccines and to synergize with immune checkpoint blockade.\"}]","Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity | PDF",1790010106]